Psyence Biomedical Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $2,751,585.

Profit Margin

Psyence Biomedical Ltd. (NASDAQ:PBM): Profit margin
2024 0 -51.15M

PBM Income Statement (2023 – 2023)

2023
Revenue
Revenue
0
Cost of revenue
240
Gross profit
-240
Operating exp.
Research and development
954.59K
Selling and marketing
80.60K
Total operating expenses
2.75M
Operating income
-2.75M
Other income (expenses), net
-48.40M
Income before tax
-51.15M
Income tax expense
0
Net income
-51.15M
Earnings per share
Basic EPS
-7.85
Diluted EPS
-7.85